-
Another "CRISPR Calamity"? U.K. Team Reports CRISPR-Induced Gene Rearrangements
New Findings Call the Precision of CRISPR-Cas9 Gene Editing into Question
-
Enabling the Rise of a CRISPR World
As the World Debates Genome Editing Regulations, the Scientific Community Continues the Push to Democratize CRISPR
-
Top 10 Biopharma IPOs of January—June 2018
Number of Companies Going Public, and the Amount They Raise, Show Growth
-
Hearing the Light
Optogenetics Provides Bright New Prospects for Hearing Restoration